The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
A comprehensive review and update on ulcerative colitis,
Abstract
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that causes continuous mucosal inflammation extending from the rectum to the more proximal colon, with variable extents. UC is characterized by a relapsing and remitting course. UC was first described by Samuel Wilks in 1859 and it is more common than Crohn's disease worldwide. The overall incidence and prevalence of UC is reported to be 1.2-20.3 and 7.6-245 cases per 100,000 persons/year respectively. UC has a bimodal age distribution with an incidence peak in the 2nd or 3rd decades and followed by second peak between 50 and 80 years of age. The key risk factors for UC include genetics, environmental factors, autoimmunity and gut microbiota. The classic presentation of UC include bloody diarrhea with or without mucus, rectal urgency, tenesmus, and variable degrees of abdominal pain that is often relieved by defecation. UC is diagnosed based on the combination of clinical presentation, endoscopic findings, histology, and the absence of alternative diagnoses. In addition to confirming the diagnosis of UC, it is also important to define the extent and severity of inflammation, which aids in the selection of appropriate treatment and for predicting the patient's prognosis. Ileocolonoscopy with biopsy is the only way to make a definitive diagnosis of UC. A pathognomonic finding of UC is the presence of continuous colonic inflammation characterized by erythema, loss of normal vascular pattern, granularity, erosions, friability, bleeding, and ulcerations, with distinct demarcation between inflamed and non-inflamed bowel. Histopathology is the definitive tool in diagnosing UC, assessing the disease severity and identifying intraepithelial neoplasia (dysplasia) or cancer. The classical histological changes in UC include decreased crypt density, crypt architectural distortion, irregular mucosal surface and heavy diffuse transmucosal inflammation, in the absence of genuine granulomas. Abdominal computed tomographic (CT) scanning is the preferred initial radiographic imaging study in UC patients with acute abdominal symptoms. The hallmark CT finding of UC is mural thickening with a mean wall thickness of 8 mm, as opposed to a 2-3 mm mean wall thickness of the normal colon. The Mayo scoring system is a commonly used index to assess disease severity and monitor patients during therapy. The goals of treatment in UC are three fold-improve quality of life, achieve steroid free remission and minimize the risk of cancer. The choice of treatment depends on disease extent, severity and the course of the disease. For proctitis, topical 5-aminosalicylic acid (5-ASA) drugs are used as the first line agents. UC patients with more extensive or severe disease should be treated with a combination of oral and topical 5-ASA drugs +/- corticosteroids to induce remission. Patients with severe UC need to be hospitalized for treatment. The options in these patients include intravenous steroids and if refractory, calcineurin inhibitors (cyclosporine, tacrolimus) or tumor necrosis factor-α antibodies (infliximab) are utilized. Once remission is induced, patients are then continued on appropriate medications to maintain remission. Indications for emergency surgery include refractory toxic megacolon, colonic perforation, or severe colorectal bleeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
The Characteristics of Ulcerative Colitis Associated With Autoimmune Pancreatitis
Park, S. H., Kim, D., Ye, B. D., Yang, S., Kim, J. H., Yang, D., Jung, K. W., Kim, K., Byeon, J., Myung, S., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31827fd4a2 · Cited by 53
Conversion of the failing ileoanal pouch to reservoir-ileostomy rather than to ileostomy alone
Ecker, K. W., Haberer, M., & Feifel, G. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02054684 · Cited by 47
Infliximab for refractory ulcerative proctitis
Bouguen, G., Roblin, X., Bourreille, A., FEIER, L., Filippi, J., Nancey, S., Bretagne, J., Flourié, B., Hébuterne, X., Bigard, M., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04293.x · Cited by 46
Kiran, R. P., Ali, U. A., Nisar, P. J., Khoury, W., Gu, J., Shen, B., Remzi, F. H., Hammel, J., Lavery, I. C., Fazio, V. W., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828e7417 · Cited by 40
Feagins, L. A., Melton, S. D., Iqbal, R., Dunbar, K. B., & Spechler, S. J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f4ae · Cited by 38
Endoscopic evaluation of patients with inflammatory bowel disease
Simpson, P. A., & Papadakis, K. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20398 · Cited by 37
Restorative proctocolectomy for distal ulcerative colitis
Brunel, M., Penna, C., Tiret, E., Balladur, P., & Parc, R. (1999) · Gut · doi:10.1136/gut.45.4.542 · Cited by 37
Lindsay, J. O., Bergman, A., Patel, A. S., Alesso, S. M., & Peyrin‐Biroulet, L. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13197 · Cited by 36
Medical management of severe ulcerative colitis
Chang, J. C., & Cohen, R. D. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.02.005 · Cited by 36
Ganji‐Arjenaki, M., Nasri, H., & Rafieian‐Kopaei, M. (2017) · Journal of Nephropathology · doi:10.15171/jnp.2017.42 · Cited by 35
Extraintestinal Manifestations Associated with Inflammatory Bowel Disease
Brown, S. R., & Coviello, L. C. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.08.002 · Cited by 34
Malaty, H. M., Lo, G. H., & Hou, J. K. (2017) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s136383 · Cited by 34
Use of Oral Moist Snuff and Inflammatory Bowel Disease
Persson, P.-G., Hellers, G., & Ahlbom, A. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.6.1101 · Cited by 33
Disease Characteristics of Inflammatory Bowel Disease (IBD)
Subasinghe, D., Nawarathna, N. M. M., & Samarasekera, D. N. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1588-5 · Cited by 33
Advanced endoscopy imaging in inflammatory bowel diseases
Kießlich, R., & Neurath, M. F. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.10.034 · Cited by 33
Restorative Proctectomy With Ileal Pouch-Anal Anastomosis in Obese Patients
Canedo, J., Pinto, R. A., McLemore, E. C., Rosen, L., & Wexner, S. D. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181db7029 · Cited by 32
African-American inflammatory bowel disease in a Southern U.S. health center
Veluswamy, H., Suryawala, K., Sheth, A. R., Wells, S., Salvatierra, E., Cromer, W. E., Chaitanya, G. V., Painter, A., Patel, M., Manas, K. J., et al. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-104 · Cited by 31
Mesalazine vanishing time from rectal mucosa following its topical administration
Pimpo, M. T., Galletti, B., Palumbo, G., Viscido, A., Gentile, P., Caprilli, R., & Frieri, G. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.08.003 · Cited by 30
Harms, B. A., Andersen, A. B., & Starling, J. R. (1992) · PubMed · Cited by 28
Colorectal cancer surveillance in patients with inflammatory bowel disease: What ¡s new?
Guagnozzi, D. (2012) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v4.i4.108 · Cited by 27
What is the importance of appendectomy in the natural history of IBD?
Radford‐Smith, G. L. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20623 · Cited by 24
Is IBD an autoimmune disorder?
Das, K. M., & Biancone, L. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20723 · Cited by 23
Alterations of pulmonary function in patients with inflammatory bowel diseases
Lu, D., Ji, X., Ji, Y., Wang, S.-X., & Zhang, W. (2016) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.191877 · Cited by 23
Pouchitis: A spectrum of diseases
Shen, B., & Lashner, B. A. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0011-3 · Cited by 22
Ford, A. C., Moayyedi, P., Berčík, P., Morgan, D. G., Bolino, C., Pinto-Sánchez, M. I., & Reinisch, W. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.117 · Cited by 22
Kopylov, U., Boucher, G., Waterman, M., Rivers, C. R., Patel, M., Cho, J. H., Colombel, J. F., Duerr, R. H., Binion, D. G., McGovern, D. P. B., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000913 · Cited by 17
Role of Histologic Inflammation in the Natural History of Ulcerative Colitis
Patil, D. T., Moss, A. C., & Odze, R. D. (2016) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.06.009 · Cited by 16
Postoperative management of ulcerative colitis and crohn’s disease
Keswani, R. N., & Cohen, R. D. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0081-2 · Cited by 8
Established Management Paradigms in IBD: Treatment Targets and Therapeutic Tools
Regueiro, M. D., Greer, J. B., & Hanauer, S. B. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2016.16 · Cited by 8
Ladd, A. M., Jia, Y., Yu, C. H., Elhanafi, S. E., Dwivedi, A. K., Liu, J., Song, G., Hall, M., & Zuckerman, M. J. (2016) · Southern Medical Journal · doi:10.14423/smj.0000000000000571 · Cited by 7
Cited by
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
Spinelli, A., Bonovas, S., Burisch, J., Kucharzik, T., Adamina, M., Annese, V., Bachmann, O., Bettenworth, D., Chaparro, M., Czuber-Dochan, W., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab177 · Cited by 546
Annotating metabolite mass spectra with domain-inspired chemical formula transformers
Goldman, S., Wohlwend, J., Stražar, M., Haroush, G., Xavier, R. J., & Coley, C. W. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00708-3 · Cited by 87
Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis
Bhambhvani, H. P., & Zamora, A. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001952 · Cited by 59
Ahmad, H. A., East, J. E., Panaccione, R., Travis, S., Canavan, J. B., Usiskin, K., & Byrne, M. F. (2023) · Intestinal Research · doi:10.5217/ir.2023.00020 · Cited by 37
Liu, C., He, Y.-X., Zhang, J.-N., Yang, F., Wang, S.-Y., Hu, J.-L., & Yu, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2022.154490 · Cited by 27
Metadata
- Authors
- Gajendran, M., Loganathan, P., Jimenez, G., Catinella, A. P., Ng, N., Umapathy, C., Ziade, N., & Hashash, J. G.
- Venue
- Disease-a-Month
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 65
- Issue
- 12
- Pages
- 100851
- ISSN
- 0011-5029 (ISSN-L)
- OpenAlex
- W2919372986
- Cited by
- 638
- References
- 230
- FWCI
- 26.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.